About this Research Topic
In recent years, brain science research applying molecular biology has made great progress, and has achieved research results approaching the pathophysiology of psychiatric disorders. In addition, genetic research, especially the results of comprehensive analysis of large-scale sample sizes, has brought about unprecedented scientifically reliable results. Furthermore, brain images are expected to contribute to the diagnosis of general psychiatric disorders such as schizophrenia and mood disorders because not only structural search but also functional methodologies are advancing. On the other hand, descriptive methodologies are still the mainstream in psychiatric clinical practice, and it must be said that the research results that can spread to general clinical practice are still limited.
This Research Topic provides an opportunity to get a comprehensive overview of the clinical application of various research results to psychiatric diseases such as schizophrenia, depression and PTSD. We aim at featuring test methods based on genetic analysis research including epigenetics and Polygenic Risk Score, brain images and cerebral magnetic diagrams, pharmaceuticals and neuromodulation methods. In addition, we aim at identifying technologies and test methods that support precise psychiatric care, and future map of psychiatric clinical practice such as psychiatric diagnosis system. We encourage studies including opinions aimed at clinical application such as specificity and sensitivity based on high-quality research results from a wide range of areas.
We welcome Original Research, Reviews and Opinion articles on (but not limited to) the following subtopics:
• Genetic and epigenetic research studies applied to clinical psychiatry;
• Neuroimaging and neuromodulation studies applied to clinical psychiatry;
• Various research results to the diagnosis and treatment of psychiatric disorders, namely schizophrenia, depression and PTSD;
• Opinion manuscripts on the future of mental illness diagnostic systems are welcomed without research results.
This Research Topic provides an opportunity to get a comprehensive overview of the clinical application of various research results to psychiatric diseases such as schizophrenia, depression and PTSD. We aim at featuring test methods based on genetic analysis research including epigenetics and Polygenic Risk Score, brain images and cerebral magnetic diagrams, pharmaceuticals and neuromodulation methods. In addition, we aim at identifying technologies and test methods that support precise psychiatric care, and future map of psychiatric clinical practice such as psychiatric diagnosis system. We encourage studies including opinions aimed at clinical application such as specificity and sensitivity based on high-quality research results from a wide range of areas.
We welcome Original Research, Reviews and Opinion articles on (but not limited to) the following subtopics:
• Genetic and epigenetic research studies applied to clinical psychiatry;
• Neuroimaging and neuromodulation studies applied to clinical psychiatry;
• Various research results to the diagnosis and treatment of psychiatric disorders, namely schizophrenia, depression and PTSD;
• Opinion manuscripts on the future of mental illness diagnostic systems are welcomed without research results.
Keywords: molecular, clinical psychiatry, genetic analysis, epigenetic, neuromodulation, neuroimaging, ptsd, schizophrenia, depression, mood disorders
Important Note: All contributions to this Research Topic must be within the scope of the section and journal to which they are submitted, as defined in their mission statements. Frontiers reserves the right to guide an out-of-scope manuscript to a more suitable section or journal at any stage of peer review.
